Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLYM
1676
DELISTED
Plymouth Industrial REIT
PLYM
| $3.82M | 0.01% |
199,212
+900
| +0.5% | +$17K |
|
1677
Popular Inc
BPOP
$11.3B
| $3.81M | 0.01% |
57,525
-80,400
| -58% | -$5.59M |
|
|
FIRY
1678
Firy Inc
FIRY
$148M
| $3.81M | 0.01% |
376,431
+79,351
| +27% | +$1.46M |
|
|
VOXX
1679
DELISTED
VOXX International Corporation Class A
VOXX
| $3.81M | 0.01% |
455,022
-141,300
| -24% | -$1.28M |
|
1680
Radian Group
RDN
$4.98B
| $3.8M | 0.01% |
199,500
+67,900
| +52% | +$1.32M |
|
|
DICE
1681
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $3.79M | 0.01% |
+121,300
| New | +$3.96M |
|
|
TPC
1682
Tutor Perini Cor
TPC
$5.09B
| $3.77M | 0.01% |
499,080
-9,300
| -2% | -$65.9K |
|
|
DEA
1683
Easterly Government Properties
DEA
$1.17B
| $3.77M | 0.01% |
105,560
+19,160
| +22% | +$745K |
|
|
FLG
1684
Flagstar Bank National Association
FLG
$5.92B
| $3.77M | 0.01% |
145,947
-509,261
| -78% | -$13.6M |
|
1685
Atlanticus Holdings
ATLC
$1.56B
| $3.76M | 0.01% |
143,658
-16,700
| -10% | -$446K |
|
|
PRPH
1686
DELISTED
ProPhase Labs
PRPH
| $3.75M | 0.01% |
38,941
+1,260
| +3% | +$136K |
|
1687
Bank of Hawaii
BOH
$3.17B
| $3.75M | 0.01% |
48,300
+17,700
| +58% | +$1.37M |
|
|
BPMC
1688
DELISTED
Blueprint Medicines
BPMC
| $3.74M | 0.01% |
+85,400
| New | +$4.1M |
|
1689
Crawford & Co Class B
CRD.B
$593M
| $3.72M | 0.01% |
701,410
-25,100
| -3% | -$140K |
|
1690
LyondellBasell Industries
LYB
$20.6B
| $3.72M | 0.01% |
44,800
-238,200
| -84% | -$19.5M |
|
1691
Comfort Systems
FIX
$62.4B
| $3.72M | 0.01% |
+32,300
| New | +$3.76M |
|
|
AKRO
1692
DELISTED
Akero Therapeutics
AKRO
| $3.7M | 0.01% |
67,600
+3,500
| +5% | +$150K |
|
|
ETRN
1693
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $3.7M | 0.01% |
552,499
+537,699
| +3,633% | +$4.17M |
|
|
RNAM
1694
DELISTED
Avidity Biosciences
RNAM
| $3.7M | 0.01% |
166,600
+42,600
| +34% | +$635K |
|
1695
Friedman Industries
FRD
$331M
| $3.69M | 0.01% |
377,462
-16,320
| -4% | -$147K |
|
1696
Schrodinger
SDGR
$1.32B
| $3.69M | 0.01% |
197,600
-32,300
| -14% | -$670K |
|
|
API
1697
Agora
API
$392M
| $3.66M | 0.01% |
936,666
-242,683
| -21% | -$801K |
|
1698
Archrock
AROC
$6.08B
| $3.66M | 0.01% |
407,100
-205,228
| -34% | -$1.64M |
|
|
PFSW
1699
DELISTED
PFSweb, Inc.
PFSW
| $3.65M | 0.01% |
593,454
-13,356
| -2% | -$125K |
|
1700
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
| $3.64M | 0.01% |
246,200
-131,800
| -35% | -$2.2M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.